EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C13H16N2.HCl |
| Net Charge | 0 |
| Average Mass | 236.746 |
| Monoisotopic Mass | 236.10803 |
| SMILES | Cc1cccc([C@H](C)c2cncn2)c1C.Cl |
| InChI | InChI=1S/C13H16N2.ClH/c1-9-5-4-6-12(10(9)2)11(3)13-7-14-8-15-13;/h4-8,11H,1-3H3,(H,14,15);1H/t11-;/m0./s1 |
| InChIKey | VPNGEIHDPSLNMU-MERQFXBCSA-N |
| Roles Classification |
|---|
| Biological Role: | analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. |
| Applications: | antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. antipsychotic agent Antipsychotic drugs are agents that control agitated psychotic behaviour, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. anti-arrhythmia drug A drug used for the treatment or prevention of cardiac arrhythmias. Anti-arrhythmia drugs may affect the polarisation-repolarisation phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibres. neuroprotective agent Any compound that can be used for the treatment of neurodegenerative disorders. sedative A central nervous system depressant used to induce drowsiness or sleep or to reduce psychological excitement or anxiety. analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| dexmedetomidine hydrochloride (CHEBI:31472) has part dexmedetomidine (CHEBI:4466) |
| dexmedetomidine hydrochloride (CHEBI:31472) has role analgesic (CHEBI:35480) |
| dexmedetomidine hydrochloride (CHEBI:31472) has role anti-arrhythmia drug (CHEBI:38070) |
| dexmedetomidine hydrochloride (CHEBI:31472) has role antineoplastic agent (CHEBI:35610) |
| dexmedetomidine hydrochloride (CHEBI:31472) has role antipsychotic agent (CHEBI:35476) |
| dexmedetomidine hydrochloride (CHEBI:31472) has role neuroprotective agent (CHEBI:63726) |
| dexmedetomidine hydrochloride (CHEBI:31472) has role sedative (CHEBI:35717) |
| dexmedetomidine hydrochloride (CHEBI:31472) is a medetomidine hydrochloride (CHEBI:48556) |
| dexmedetomidine hydrochloride (CHEBI:31472) is enantiomer of levomedetomidine hydrochloride (CHEBI:48557) |
| Incoming Relation(s) |
| levomedetomidine hydrochloride (CHEBI:48557) is enantiomer of dexmedetomidine hydrochloride (CHEBI:31472) |
| IUPAC Name |
|---|
| 4-[(1S)-1-(2,3-dimethylphenyl)ethyl]-1H-imidazole hydrochloride |
| Synonyms | Source |
|---|---|
| 4-((S)-α,2,3-trimethylbenzyl)imidazole monohydrochloride | ChemIDplus |
| Cepedex | ChEMBL |
| Dexdomitor | ChEMBL |
| Igalmi | ChEMBL |
| Sedadex | ChEMBL |
| Sileo | ChEMBL |
| Brand Names | Source |
|---|---|
| Dexmedetomidine accord | ChEMBL |
| Precedex | KEGG DRUG |
| Manual Xrefs | Databases |
|---|---|
| D01205 | KEGG DRUG |
| Registry Numbers | Sources |
|---|---|
| Beilstein:8937629 | Beilstein |
| CAS:145108-58-3 | ChemIDplus |